The Evolution of access to essential medicines for the treatment of HIV/AIDS

Statement 5 Sep 2025

Statement on the publication of the 24th WHO Model List of Essential Medicines

Responding to the publication of the updated WHO Model List of Essential Medicines (EML), IFPMA Director General, Dr. David Reddy said: “The inclusion of innovative medicines on the updated EML highlights how scientific advances are transforming how we prevent, treat and cure disease, and reinforces the importance of ensuring patients everywhere can benefit from them. ...

Key access pathways and bottlenecks for medicines in LMICs

Medicines and vaccines have transformed the way we prevent, treat, and cure diseases. Bringing these to people around the world requires more than scientific breakthroughs – it demands collaboration across the entire innovation and access pathway. From discovery and development to regulatory approval, supply, procurement and local delivery, each step plays a critical role in...

WHA78 constituency statement on universal health coverage (UHC) and primary healthcare (PHC)

On 24 May 2025 at the 78th session of the World Health Assembly, the International Council of Nurses (ICN) delivered a statement on behalf of the World Health Professions Alliance (WHPA) on UHC and PHC.